PENTAIR WKN: A115FG ISIN: IE00BLS09M33 Kürzel: PNR Forum: Aktien Thema: Hauptdiskussion
Pentair plc provided earnings guidance for the first quarter of 2024 and fiscal year 2024. The Company introduces first quarter 2024 GAAP EPS of approximately $0.81 to $0.84. The Company expects first quarter sales to be down approximately 2% to 3% on a reported basis compared to first quarter 2023. Operating income approx. up 3% to 7%. Net income from continuing operations—as reported approx. $135 million to $140 million For the year, The Company is introducing 2024 GAAP EPS guidance of approximately $3.82 to $3. This is an increase of 11% to 13% compared to 2023. The Company anticipates full year 2024 sales to increase 2% to 3% on a reported basis. Operating income approx. up 17% to 20%. Net income from continuing operations—as reported approx. $636 million to $653 million.
|
Thema | ||
---|---|---|---|
1 | GAMESTOP Hauptdiskussion | -7,07 % | |
2 | Jaguar Health nach RS | -12,10 % | |
3 | NVIDIA Hauptdiskussion | +5,26 % | |
4 | AIXTRON Hauptdiskussion | -4,12 % | |
5 | Novavax Hauptdiskussion | -0,92 % | |
6 | CYTOMX THERAPEUTICS INC. Hauptdiskussion | +1,13 % | |
7 | Pineapple Energy | +6,19 % | |
8 | Lilium Aktie | -2,56 % | |
9 | NEL ASA Hauptdiskussion | +15,86 % | |
10 | Hexagon Purus | +6,55 % | Alle Diskussionen |
|
Thema | ||
---|---|---|---|
1 | GAMESTOP Hauptdiskussion | -7,07 % | |
2 | Jaguar Health nach RS | -12,10 % | |
3 | NVIDIA Hauptdiskussion | +5,26 % | |
4 | AIXTRON Hauptdiskussion | -4,12 % | |
5 | Novavax Hauptdiskussion | -0,92 % | |
6 | CYTOMX THERAPEUTICS INC. Hauptdiskussion | +1,13 % | |
7 | Pineapple Energy | +6,19 % | |
8 | Lilium Aktie | -2,56 % | |
9 | Hexagon Purus | +6,55 % | |
10 | NEL ASA Hauptdiskussion | +15,86 % | Alle Diskussionen |